Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination

The benefits of arterial hypertension (AH) combined treatment are discussed. A combined medication, Tarka (calcium antagonist verapamil SR plus ACE inhibitor trandolapril), is used as an example to demonstrate high antihypertensive activity, metabolic neutrality, cardio- and nephroprotection. Not on...

Full description

Bibliographic Details
Main Author: V. I. Makolkin
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2008-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
arterial hypertension
combined treatment
cardioprotection
nephroprotection
proteinuria
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1633
id doaj-5568ed04939d48cb96bb37028e8727db
record_format Article
spelling doaj-5568ed04939d48cb96bb37028e8727db2021-07-28T13:50:48Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-12-017650551350Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combinationV. I. Makolkin0I.M. Sechenov Moscow Medical Academy. MoscowThe benefits of arterial hypertension (AH) combined treatment are discussed. A combined medication, Tarka (calcium antagonist verapamil SR plus ACE inhibitor trandolapril), is used as an example to demonstrate high antihypertensive activity, metabolic neutrality, cardio- and nephroprotection. Not only Tarka components per se, but also their combination was effective in large clinical trials. Indications for this combined medication are presented.https://cardiovascular.elpub.ru/jour/article/view/1633arterial hypertensioncombined treatmentcardioprotectionnephroprotectionproteinuria
collection DOAJ
language Russian
format Article
sources DOAJ
author V. I. Makolkin
spellingShingle V. I. Makolkin
Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
Кардиоваскулярная терапия и профилактика
arterial hypertension
combined treatment
cardioprotection
nephroprotection
proteinuria
author_facet V. I. Makolkin
author_sort V. I. Makolkin
title Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
title_short Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
title_full Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
title_fullStr Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
title_full_unstemmed Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
title_sort combined treatment of arterial hypertension: focus on calcium antagonist and ace inhibitor combination
publisher «SILICEA-POLIGRAF» LLC
series Кардиоваскулярная терапия и профилактика
issn 1728-8800
2619-0125
publishDate 2008-12-01
description The benefits of arterial hypertension (AH) combined treatment are discussed. A combined medication, Tarka (calcium antagonist verapamil SR plus ACE inhibitor trandolapril), is used as an example to demonstrate high antihypertensive activity, metabolic neutrality, cardio- and nephroprotection. Not only Tarka components per se, but also their combination was effective in large clinical trials. Indications for this combined medication are presented.
topic arterial hypertension
combined treatment
cardioprotection
nephroprotection
proteinuria
url https://cardiovascular.elpub.ru/jour/article/view/1633
work_keys_str_mv AT vimakolkin combinedtreatmentofarterialhypertensionfocusoncalciumantagonistandaceinhibitorcombination
_version_ 1721271230387978240

Similar Items